提供: Vaccipedia | Resources for Vaccines, Tropical medicine and Travel medicine
(
差分)
← 古い版 | 最新版 (差分) | 新しい版 → (差分)
ナビゲーションに移動
検索に移動
Navigation Menu
|
|
General issues of Vaccine
|
|
General issues of Tropical med.
|
|
General issues of Travel med.
|
|
Trematode (fluke, distoma)
|
|
poliovirus
- family Picornaviridae, genus Enterovirus
- Human enterovirus A, B, C, D
- PV belongs to HEV-C
- EV71 belongs to HEV-A
- EV68 (EV-D68) belongs to HEV-D
- non-enveloped single stranded positive sense RNA virus
- 3 serotypes
- wPV2 already eradicated in 2015
- wPV3 was declared to be eradicated in 17 October 2019 by WHO
- wPV1 is still circulating in Pakistan and Afghanistan
- African region was certified as wild polio-free in 2020 by WHO
VDPV
- cVDPV1 and cVDPV2 are endemic in Africa and Southeast Asia as well as in Pakistan and Afghanistan
- in recent 12 months no local transmission in Southeast Asia
- cVDPV3 is not identified so far
- VDPV is relatively physically stable in environment but cannot keep infectivity not for long time, thus continuous detection of VDPV in enviromnent means continuous transmission and/or excretion of VDPV from people living in the community
- distribution of breech (disinfectant) and/or irradication ultraviolet light may be effective against PV/VDPV
- threshold of immunization coverage to maintain PV/VDPV free is 85-90%
==Global Polio Eradication
- strategies
- extensive immunization with OPV or IPV
- surveillance of acute flaccid paralysis
- lab diagnosis
- AFP cases and true poliovirus infection overlap very little
- ⇔Variola cases and true smallpox infection overlapped almost identically
- novel OPV2
- using genetically modified stain
- more stabilized genomically
clinical
- mostly asymptomatic
- many mild manifestation
- polio paralytic cases 79% by wPV1, 8% by wPV2, 13% by wPV3 in 2010